Delivery of oligonucleotide-based therapeutics: challenges and opportunities

preview_player
Показать описание
COST Action "DARTER" recently published a review of the delivery hurdles and solutions in the developmento of therapeutic oligonucleotides.

This video is based upon work from COST Action DARTER 17103 , supported by COST (European Cooperation in Science and Technology).

COST (European Cooperation in Science and Technology) is a funding agency
for research and innovation networks. Our Actions help connect research initiatives
across Europe and enable scientists to grow their ideas by sharing them with their
Рекомендации по теме